Abstract
Skin reactions related to secukinumab are uncommon. Although the initial phase 3 studies of this medication reported infection and urticaria as adverse cutaneous events, other cases of unique adverse events have since been reported. We are presenting a patient who developed an exuberant hand and foot reaction after starting secukinumab.
MeSH terms
-
Adult
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Blister / chemically induced
-
Blister / pathology*
-
Dermatitis, Atopic / complications
-
Drug Eruptions / etiology
-
Drug Eruptions / pathology*
-
Female
-
Foot Dermatoses / chemically induced
-
Foot Dermatoses / pathology*
-
Hand Dermatoses / chemically induced
-
Hand Dermatoses / pathology*
-
Humans
-
Psoriasis / drug therapy
Substances
-
Antibodies, Monoclonal, Humanized
-
secukinumab